Aarvik Therapeutics: Funding, Investors & Team (Oct 2026)
Aarvik Therapeutics combines a unique, proprietary modular platform with multiple target mechanisms to develop novel molecules with an improved therapeutic index for oncology targets. Backed by the extensive scientific research, development, and investment expertise of its founders and Board members, Aarvik Therapeutics is applying its vision and passion to create transformational benefits for cancer patients.
Aarvik Therapeutics has raised $1.2M across 2 funding rounds on record, the most recent a Seed announced in Oct 2025.
Aarvik Therapeutics Company Profile and Key Stats
Latest funding round on record: Oct 2025.
Aarvik Therapeutics Funding Rounds
1 of 2 rounds was announced without a disclosed amount and is excluded from the total.
Aarvik Therapeutics raised $1.2M in a Seed announced in Dec 2024.
10 months later, a Seed was announced in Oct 2025 with no disclosed amount.
Aarvik Therapeutics Founders and Leadership Team
Contact details for the Aarvik Therapeutics team: 2 of 2 have an email address on file, 1 has a LinkedIn profile.
Start 14-day free trial →Aarvik Therapeutics Funding Compared to Other Biotechnology Startups
Funded Startups Like Aarvik Therapeutics in Biotechnology and Fremont
Companies Similar to Aarvik Therapeutics
Prolific Machines is a biotech company located in San Francisco, California, that was established in 2020. It…
Altay Therapeutics is a biotech company focused on finding and discovering small molecule therapies for…
Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…
Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain…
Tiny Health offers a gut health test specifically designed for mothers and babies aged 0 to 3 years.…
Junevity is dedicated to using cutting-edge transcription factor medicines to combat age-related diseases.…
Arkea Bio creates technology aimed at reducing greenhouse gas (GHG) emissions in the agricultural sector.
Serán is a contract development and manufacturing organization providing a comprehensive suite of…
Precision’s goal is to provide breakthrough treatments for the one billion patients worldwide suffering from…
Enveda is a biotechnology company that utilizes AI-powered tools to explore and characterize molecules from…
Avery Therapeutics, Inc. is a company dedicated to developing tissue engineered therapeutics to treat…
Aarvik Therapeutics Funding FAQs
What does Aarvik Therapeutics do?
Aarvik Therapeutics combines a unique, proprietary modular platform with multiple target mechanisms to develop novel molecules with an improved therapeutic index for oncology targets. Backed by the extensive scientific research, development, and investment expertise of its founders and Board members, Aarvik Therapeutics is applying its vision and passion to create transformational benefits for cancer patients.
How much funding has Aarvik Therapeutics raised?
Aarvik Therapeutics has raised $1.2M across 2 rounds on record.
When did Aarvik Therapeutics last raise funding?
Aarvik Therapeutics' most recent funding round on record was announced in Oct 2025. The amount was not disclosed.
Who founded Aarvik Therapeutics?
FundedIQ lists Jagath Reddy Junutula (Founder) at Aarvik Therapeutics.
Who is the CEO of Aarvik Therapeutics?
Jagath Reddy Junutula, PhD is listed as CEO at Aarvik Therapeutics.
Where is Aarvik Therapeutics headquartered?
Aarvik Therapeutics is based in Fremont, California, United States.
How many employees does Aarvik Therapeutics have?
Aarvik Therapeutics is in the 11-50 employee band.
About FundedIQ's Aarvik Therapeutics Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Aarvik Therapeutics is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.